Luis Borges
Chief Tech/Sci/R&D Officer at METAGENOMI, INC.
Net worth: 1 M $ as of 31/05/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert Bradway | M | 61 | 18 years | |
| Pamela Wapnick | F | 58 | 11 years | |
| Willard Dere | M | 70 | 15 years | |
| Joseph Jimenez | M | 64 | 5 years | |
| Brian Thomas | M | 55 | 8 years | |
| Gregory Russotti | M | 57 | 4 years | |
| Jian Irish | M | 60 | 3 years | |
| Timothy Walbert | M | 57 | 2 years | |
| Simren Delaney | M | 38 | 4 years | |
| Matthew Busch | M | 50 | 20 years | |
| Esteban Santos | M | 56 | 17 years | |
| Kimberly Blackwell | M | 55 | 3 years | |
| Robert Eckert | M | 69 | 21 years | |
| Jürgen Eckhardt | M | 57 | 4 years | |
| David Reese | M | 61 | 19 years | |
| Greg Garland | M | 66 | 11 years | |
| Cynthia Butitta | F | 69 | 3 years | |
| Hyam Levitsky | M | 66 | 5 years | |
| Tyler Jacks | M | 63 | 12 years | |
| Alessandro Riva | M | 63 | 3 years | |
| Daphne Quimi | F | 58 | 2 years | |
| Simon Harnest | M | 37 | 3 years | |
| Mark J. Taisey | M | - | 10 years | |
| Adrienne Farid | M | 62 | 3 years | |
| Sebastián Bernales | M | 48 | 4 years | |
| Rachna Khosla | F | - | 11 years | |
| Derek Miller | M | - | 21 years | |
| Risa Stack | M | 55 | 2 years | |
| Sarah Noonberg | M | 56 | 1 years | |
| Christopher Brown | M | 35 | 1 years | |
| Michael Conway | M | 48 | 2 years | |
| Alan Brooks | M | 58 | 5 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| William Ringo | M | 78 | 7 years | |
| David W. Beier | M | 75 | 10 years | |
| Kevin Boyle | M | 50 |
Kuur Therapeutics Ltd.
 Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | 3 years |
| R. Lee Douglas | M | 72 | 15 years | |
| Osvaldo Flores | M | - | - | |
| Michael Kelly | M | 67 | 14 years | |
| Dennis Fenton | M | 72 | 27 years | |
| Brian Atwood | M | 71 | 14 years | |
| Robert Steven Sikorski | M | - | 8 years | |
| Kevin Sharer | M | 76 | 20 years | |
| Marc M. P. de Garidel | M | 66 | 15 years | |
| Gregg Stephen Sando | M | - |
Kuur Therapeutics Ltd.
Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | 12 years |
| Paul Eisenberg | M | - | 14 years | |
| Sheila Gujrathi | M | 53 | 4 years | |
| Sean E. Harper | M | 61 | 16 years | |
| Gregory L. Tewalt | M | - | - | |
| Michael Severino | M | 58 | 10 years | |
| Raymond C. Jordan | M | 70 | 7 years | |
| Diana McKenzie | F | 59 | 12 years | |
| Vasant Prakash Gandhi | M | - | 5 years | |
| John Moriarty | M | 56 | 6 years | |
| Craig Shepherd | M | - | 7 years | |
| Sean B. W. Martin | M | 61 | - | |
| Leonard Schaeffer | M | 78 | 9 years | |
| Cynthia Patton | F | 62 | 15 years | |
| Garry Nicholson | M | 69 | 4 years | |
| Thomas Zindrick | M | 65 | 8 years | |
| Marco Renoldi | M | 67 | 3 years | |
| Annette L. Such | F | 55 | - | |
| Yi Ning Zhao | M | 53 | 9 years | |
| Robert Azelby | M | 56 | 5 years | |
| Martin Forrest | M | - | 2 years | |
| Joseph Newell | M | 54 | 7 years | |
| Susan Lundeen Smuck | F | 57 | 12 years | |
| Erin Lavelle | F | 46 | 15 years | |
| Andreas Grauer | M | 63 | - | |
| Nathan Hardy | M | 48 | 10 years | |
| Preston Klassen | M | 55 | 7 years | |
| William P. Sheridan | M | 69 | 5 years | |
| Kevin P. Baker | M | 63 | 12 years | |
| Ronald Sugar | M | 75 | 14 years | |
| George Morrow | M | 72 | 10 years | |
| David J. Scott | M | 71 | - | |
| Rebecca M. Henderson | M | 63 | 11 years | |
| Timothy Martin | M | 55 | 3 years | |
| Linda Rubinstein | F | 58 | - | |
| Vance D. Coffman | M | 79 | 9 years | |
| Frederick Gluck | M | 88 | 13 years | |
| Anna Richo | F | 63 | 9 years | |
| Mark McDade | M | 69 | 12 years | |
| Patricia Cary Sueltz | F | 71 | 2 years | |
| J. Reason | M | 83 | 12 years | |
| Fred Cohen | M | 67 | 16 years | |
| Steven Galson | M | 67 | - | |
| Colin Love | M | 65 | - | |
| Christopher Nowers | M | - |
Kuur Therapeutics Ltd.
Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | - |
| Mike Diem | M | 54 | 4 years | |
| Thomas Johannes W. Dittrich | M | 60 | 4 years | |
| David White | M | 59 | 2 years | |
| John Smither | M | 71 | 6 years | |
| Jin Long Chen | M | 61 | 4 years | |
| François de Carbonnel | M | 78 | 10 years | |
| Cynthia Flowers | F | 64 | 5 years | |
| Frank J. Biondi | M | 79 | 15 years | |
| William Ashton | M | 73 | 16 years | |
| Kapil Dhingra | M | 64 | 6 years | |
| Rachel Lenington | F | 51 | 10 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 96 | 96.97% |
| United Kingdom | 3 | 3.03% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Luis Borges
- Personal Network
